Last deal

Amount

Seed

Stage

14.06.2023

Date

7

all rounds

$2.7M

Total amount

General

About Company
Ariel provides clinical decision support for digestive and metabolic diseases using its cloud-based platform.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Ariel

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

Ariel's platform, ADVANCE, integrates a patient's medical history, symptoms, and genetic profile to generate new insights and personalized therapeutics. By combining genetic results, systems biology, automation, and artificial intelligence, Ariel enables the stratification of patients into different disease sub-types and tailors treatments accordingly. Their mission is to simplify the personalized treatment of complex diseases and improve patient outcomes.
Contacts